East Windsor, NJ, United States of America

Robert F Doehner, Jr

This inventor holds 47 USPTO granted patents, primarily in Heterocyclic Compounds. Top assignees: American Cyanamid Company, American Home Products Corporation. Active years: 1984-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert F Doehner, Jr. Retrieved from https://idiyas.com/inventor/robert-f-doehner-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 47

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 214(Granted Patents)

Company Filing History:

46 out of 3,580

American Cyanamid Company

patents

1 out of 1,567

American Home Products Corporation

patents

Years Active: 1984-1997

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Imidazolinyl Compounds

Herbicides

Pyrroline Derivatives

Benzazoles

Benzimidazoles

Nicotinic Acids

Sulfonyl Carboxamides

Pyridinedicarboxylate

Insecticidal Processes

Quinolyl Substituted

Phenylsulfonyl Compounds

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5625082 - 2-aryl-5-(trifluoromethyl)-2-pyrroline compounds useful in the (1997-04-29),

2. 5622913 - (2-imidazolin-2-yl) fused heteropyridine compounds intermediates for the (1997-04-22),

3. 5599773 - (2-imidazolin-2-yl) fused heteropyridine compounds and use of said (1997-02-04),

4. 5599772 - (2-imidazolin-2-yl) fused heteropyridine compounds, intermediates for (1997-02-04),

5. 5571773 - (2-imidazolin-2-yl) fused heteropyridine compounds intermediates for the (1996-11-05),

6. 5565412 - (2-imidazolin-2-yl) fused heteropyridine compounds, intermediates for (1996-10-15),

7. 5565411 - (2-imidazolin-2-yl) fused heteropyridine compounds, intermediates for (1996-10-15),

8. 5563113 - (2-imidazolin-2-yl) fused heteropyridine compounds, intermediates for (1996-10-08),

9. 5554579 - (2-imidazolin-2-yl) fused heteropyridine compounds, intermediates for (1996-09-10),

10. 5536839 - (2-Imidazolin-2-yl) fused heteropyridine compounds (1996-07-16),

11. 5536702 - (2-imidazolin-2-yl) fused heteropyridine compounds and use of said (1996-07-16),

12. 5534485 - (2-imidazolin-2-yl) fused heteropyridine compounds, intermediates for (1996-07-09),

13. 5534484 - (2-imidazolin-2-yl)fused heteropyridine compounds intermediates for the (1996-07-09),

14. 5534483 - (2-imidazolin-2-yl) fused heteropyridine compounds intermediates for the (1996-07-09),

15. 5532207 - (2-imidazolin-2-yl) fused heteropyridine compounds, intermediates for (1996-07-02),

Title: Robert F. Doehner, Jr.: A Trailblazer in Chemical Innovations

Introduction

Robert F. Doehner, Jr. is a prominent inventor based in East Windsor, New Jersey. With an impressive portfolio of 47 patents, he has significantly contributed to the field of chemistry and has been involved in various innovative projects throughout his career.

Latest Patents

Among his latest inventions are the 2-aryl-5-(trifluoromethyl)-2-pyrroline compounds, which are instrumental in various chemical processes. He has also developed novel (2-imidazolin-2-yl) fused heteropyridine compounds, along with intermediate compounds for their preparation. Furthermore, his work includes a method for controlling a wide variety of annual and perennial plant species, showcasing his versatility and expertise in chemical applications.

Career Highlights

Robert's career has seen him affiliated with leading companies, including American Cyanamid Company and American Home Products Corporation. His innovative spirit and dedication to research have propelled him into the forefront of chemical invention.

Collaborations

Throughout his journey, Robert has collaborated with notable professionals like David W. Ladner and Barrington Cross. These partnerships have likely enriched his work and contributed to his extensive knowledge and understanding of complex chemical compounds.

Conclusion

Robert F. Doehner, Jr. stands out as a pioneering inventor whose contributions to chemical innovations have had a lasting impact on the industry. His extensive patent portfolio reflects his commitment to advancing technology and improving processes in various applications.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]